Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,455Revenue (TTM) $M3,842Net Margin (%)-3.3Altman Z-Score0.1
Enterprise Value $M11,183EPS (TTM) $-0.3Operating Margin %-9.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-22.7Higher ROA y-yY
Price/Book0.610-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.85-y EBITDA Growth Rate %--Current Ratio0.8Lower Leverage y-yY
Price/Free Cash Flow6.6y-y EBITDA Growth Rate %--ROA % (ttm)-0.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-2.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M223ROIC % (ttm)2.0Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENDPJoel Greenblatt 2016-09-30 Reduce-0.18%$16.56 - $24.18
($19.88)
$ 15.09-24%Reduce -97.23%28,677
ENDPJohn Paulson 2016-09-30 Reduce-0.16%$16.56 - $24.18
($19.88)
$ 15.09-24%Reduce -11.19%7,953,900
ENDPArnold Schneider 2016-09-30 Add0.11%$16.56 - $24.18
($19.88)
$ 15.09-24%Add 7.59%479,006
ENDPMario Gabelli 2016-09-30 Buy 0.01%$16.56 - $24.18
($19.88)
$ 15.09-24%New holding46,700
ENDPArnold Schneider 2016-06-30 Buy 1.3%$13.45 - $33.98
($20.83)
$ 15.09-28%New holding445,225
ENDPWallace Weitz 2016-06-30 Sold Out -0.97%$13.45 - $33.98
($20.83)
$ 15.09-28%Sold Out0
ENDPJoel Greenblatt 2016-06-30 Buy 0.19%$13.45 - $33.98
($20.83)
$ 15.09-28%New holding1,036,004
ENDPJohn Paulson 2016-06-30 Reduce-0.12%$13.45 - $33.98
($20.83)
$ 15.09-28%Reduce -5.90%8,956,300
ENDPDavid Dreman 2016-06-30 Add0.09%$13.45 - $33.98
($20.83)
$ 15.09-28%Add 1247.22%10,670
ENDPGeorge Soros 2016-03-31 Sold Out -2.46%$28.15 - $61.22
($47.57)
$ 15.09-68%Sold Out0
ENDPJohn Paulson 2016-03-31 Add1.33%$28.15 - $61.22
($47.57)
$ 15.09-68%Add 188.22%9,517,500
ENDPWallace Weitz 2016-03-31 Add0.28%$28.15 - $61.22
($47.57)
$ 15.09-68%Add 41.34%968,093
ENDPMario Gabelli 2016-03-31 Sold Out -0.01%$28.15 - $61.22
($47.57)
$ 15.09-68%Sold Out0
ENDPDavid Dreman 2016-03-31 Buy $28.15 - $61.22
($47.57)
$ 15.09-68%New holding792
ENDPSteve Mandel 2015-12-31 Sold Out -1.13%$51.46 - $71.06
($60.66)
$ 15.09-75%Sold Out0
ENDPWallace Weitz 2015-12-31 Reduce-0.62%$51.46 - $71.06
($60.66)
$ 15.09-75%Reduce -29.57%684,923
ENDPJohn Paulson 2015-12-31 Add0.6%$51.46 - $71.06
($60.66)
$ 15.09-75%Add 93.11%3,302,200
ENDPGeorge Soros 2015-12-31 Add0.17%$51.46 - $71.06
($60.66)
$ 15.09-75%Add 7.29%2,163,967
ENDPMario Gabelli 2015-12-31 Reduce$51.46 - $71.06
($60.66)
$ 15.09-75%Reduce -10.09%14,700
ENDPJohn Paulson 2015-09-30 Buy 0.63%$60.57 - $87.63
($80.05)
$ 15.09-81%New holding1,710,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENDP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIMMEL ROGER HDirector 2016-11-15Sell14,000$17.38-13.18view
HIGGINS ARTHUR JDirector 2016-05-11Buy5,000$13.89.35view
KIMMEL ROGER HDirector 2016-05-10Buy7,000$15.53-2.83view
HIGGINS ARTHUR JDirector 2016-05-10Buy11,000$15.42-2.14view
Campanelli PaulGroup President, Generics 2016-05-10Buy13,000$15.53-2.83view
INGRAM DOUGLAS SDirector 2016-05-05Sell4,513$26.59-43.25view
Spengler WilliamDirector 2016-03-17Buy1,000$29.2-48.32view
Spengler WilliamDirector 2016-03-16Buy1,000$35.24-57.18view
KIMMEL ROGER HDirector 2016-03-14Buy1,125$41.94-64.02view
Maletta Matthew JosephExec. V.P.,Chief Legal Officer 2016-03-07Buy500$44.48-66.07view

Quarterly/Annual Reports about ENDP:

News about ENDP:

Articles On GuruFocus.com
Wally Weitz Comments on Endo Nov 08 2016 
Wally Weitz's Partners Value Fund 3rd Quarter Commentary Nov 08 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
US Market Indexes Reach New Highs Aug 09 2016 
Weitz Funds Comments on Endo International Jul 20 2016 
Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary Jul 20 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
George Soros Sells Dow Chemical, Delta Air Lines Jun 06 2016 
Wally Weitz Sells Stake in Endo International, a Stock Down 75% May 26 2016 

More From Other Websites
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And... Dec 07 2016
Analysts see these large-cap U.S. stocks rising at least 30% in 2017 Dec 07 2016
UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of Endo International plc of a Class... Dec 06 2016
World’s Biggest Hedge Fund’s Best Stock Picks Dec 06 2016
Endo Begins Shipment of Generic CellCept® Dec 06 2016
Endo Begins Shipment of Generic CellCept® Dec 06 2016
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Endo... Dec 05 2016
5 Healthcare Stocks Billionaires Are Buying Dec 05 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo... Dec 05 2016
Analysts Are Bullish on Valeant Dec 02 2016
Hedge Funds Continue to Hate On Endo International plc – Ordinary Shares (ENDP) Dec 01 2016
Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report Nov 30 2016
What Do Analysts Have to Say about Mallinckrodt? Nov 29 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo... Nov 29 2016
How to buy the biggest losers Nov 28 2016
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Nov 27 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo... Nov 25 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Nov 24 2016
Mallinckrodt: The Rebound Continues Nov 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)